Skip to main content
Top
Published in: BMC Ophthalmology 1/2019

Open Access 01-12-2019 | Research article

The effect of diluting povidone-iodine on bacterial growth associated with speech

Authors: Sivashanth Gnanasekaran, Sophie Rogers, Sanj Wickremasinghe, Sukhpal S. Sandhu

Published in: BMC Ophthalmology | Issue 1/2019

Login to get access

Abstract

Background

Povidone-Iodine (PI) may be diluted when used as an antiseptic prior to an intravitreal injection in an attempt to decrease patient discomfort. This study aims to investigate the effect of diluting povidone-iodine (PI) on bacterial growth from bacterial droplet dispersal associated with speech.

Methods

Participants read a standardised script for 5 min over a blood agar plate positioned at 20 cm in a simulated position of an intravitreal injection procedure. The blood agar plates were subject to a randomised pre-application of 1% PI; 2.5% PI; 5% PI and no pre-application (control). The plates were incubated at 37 °C for 72 h and the number of Colony Forming Units (CFUs) was determined. CFUs were summarised as median and interquartile range (IQR). Wilcoxon rank sum test was used to assess pairwise comparisons of the various PI concentrations to the control group. Any trend across PI concentration was assessed using Kendall’s tau rank correlation.

Results

Twenty-one subjects participated. Control plates had a median growth of 25 CFUs (interquartile range [IQR]:15–40), 1% PI plates had a median growth of 30 CFUs (IQR:15–82), 2.5% PI had a median growth of 18 CFUs (IQR:10–32) and 5% PI had a median growth of 2 CFUs (IQR:0–5). There was significantly less bacterial growth with 5% PI compared to control (P < 0.001). Bacterial growth at 2.5% PI and 1% PI did not differ significantly from control. There was a statistically significant trend for decreasing colony count as PI concentration increased (P < 0.001).

Conclusions

PI concentrations less than 5% are not effective at reducing bacterial growth from bacterial droplet dispersal associated with speech. When using PI for pre-injection antisepsis, concentrations below 5% should be avoided.
Literature
1.
go back to reference Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432–44.CrossRef Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432–44.CrossRef
2.
go back to reference Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–31.CrossRef Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–31.CrossRef
3.
go back to reference Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012;119(12):2537–48.CrossRef Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012;119(12):2537–48.CrossRef
4.
go back to reference Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193–203.CrossRef Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193–203.CrossRef
5.
go back to reference McCannel CA. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina. 2011;31(4):654–61.CrossRef McCannel CA. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina. 2011;31(4):654–61.CrossRef
6.
go back to reference Erbahçeci IE, Ornek K. Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center. Retina. 2012;32(6):1228 author reply 1228.CrossRef Erbahçeci IE, Ornek K. Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center. Retina. 2012;32(6):1228 author reply 1228.CrossRef
7.
go back to reference Cheung CSY, Wong AWT, Lui A, Kertes PJ, Devenyi RG, Lam W-C. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology. 2012;119(8):1609–14.CrossRef Cheung CSY, Wong AWT, Lui A, Kertes PJ, Devenyi RG, Lam W-C. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology. 2012;119(8):1609–14.CrossRef
8.
go back to reference Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr, Schwartz SG, Davis JL, Murray TG, Smiddy WE, Berrocal AM, Dubovy SR, Lee WH, et al. Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center. Retina. 2011;31(4):662–8.CrossRef Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr, Schwartz SG, Davis JL, Murray TG, Smiddy WE, Berrocal AM, Dubovy SR, Lee WH, et al. Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center. Retina. 2011;31(4):662–8.CrossRef
9.
go back to reference Meredith TA, McCannel CA, Barr C, Doft BH, Peskin E, Maguire MG, Martin DF, Prenner JL, Group CoA-RMDTTR. Postinjection Endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology. 2015;122(4):817–21.CrossRef Meredith TA, McCannel CA, Barr C, Doft BH, Peskin E, Maguire MG, Martin DF, Prenner JL, Group CoA-RMDTTR. Postinjection Endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology. 2015;122(4):817–21.CrossRef
10.
go back to reference Simunovic MP, Rush RB, Hunyor AP, Chang AA. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol. 2012;96(6):862–6.CrossRef Simunovic MP, Rush RB, Hunyor AP, Chang AA. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol. 2012;96(6):862–6.CrossRef
11.
go back to reference Chen E, Lin MY, Cox J, Brown DM. Endophthalmitis after intravitreal injection: the importance of viridans streptococci. Retina. 2011;31(8):1525–33.CrossRef Chen E, Lin MY, Cox J, Brown DM. Endophthalmitis after intravitreal injection: the importance of viridans streptococci. Retina. 2011;31(8):1525–33.CrossRef
12.
go back to reference Garg SJ, Dollin M, Storey P, Pitcher JD III, Fang-Yen NH, Vander J, Hsu J, Team P-IES. Microbial spectrum and outcomes of endophthalmitis after intravitreal injection versus pars plana vitrectomy. Retina. 2016;36(2):351–9.CrossRef Garg SJ, Dollin M, Storey P, Pitcher JD III, Fang-Yen NH, Vander J, Hsu J, Team P-IES. Microbial spectrum and outcomes of endophthalmitis after intravitreal injection versus pars plana vitrectomy. Retina. 2016;36(2):351–9.CrossRef
13.
go back to reference Rao PN, Rao KN. Study of the normal conjunctival flora (bacterial and fungal) and its relations to external ocular infections. Indian J Ophthalmol. 1972;20(4):164–70.PubMed Rao PN, Rao KN. Study of the normal conjunctival flora (bacterial and fungal) and its relations to external ocular infections. Indian J Ophthalmol. 1972;20(4):164–70.PubMed
14.
go back to reference Dong Q, Brulc JM, Iovieno A, Bates B, Garoutte A, Miller D, Revanna KV, Gao X, Antonopoulos DA, Slepak VZ. Diversity of bacteria at healthy human conjunctiva. Invest Ophthalmol Vis Sci. 2011;52(8):5408–13.CrossRef Dong Q, Brulc JM, Iovieno A, Bates B, Garoutte A, Miller D, Revanna KV, Gao X, Antonopoulos DA, Slepak VZ. Diversity of bacteria at healthy human conjunctiva. Invest Ophthalmol Vis Sci. 2011;52(8):5408–13.CrossRef
15.
go back to reference Doshi RR, Leng T, Fung AE. Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina. 2012;32(3):473–6.PubMed Doshi RR, Leng T, Fung AE. Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina. 2012;32(3):473–6.PubMed
16.
go back to reference Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98(12):1769–75.CrossRef Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98(12):1769–75.CrossRef
17.
go back to reference Jiang J, Wu M, Shen T. The toxic effect of different concentrations of povidone iodine on the rabbit's cornea. Cutan Ocul Toxicol. 2009;28(3):119–24.CrossRef Jiang J, Wu M, Shen T. The toxic effect of different concentrations of povidone iodine on the rabbit's cornea. Cutan Ocul Toxicol. 2009;28(3):119–24.CrossRef
18.
go back to reference Lerhaupt KE, Mauger TF. Corneal endothelial changes from exposure to povidone iodine solution. Cutan Ocul Toxicol. 2006;25(2):63–5.CrossRef Lerhaupt KE, Mauger TF. Corneal endothelial changes from exposure to povidone iodine solution. Cutan Ocul Toxicol. 2006;25(2):63–5.CrossRef
19.
go back to reference Alp BN, Elibol O, Sargon MF, Aslan OS, Yanyali A, Karabas L, Talu H, Caglar Y. The effect of povidone iodine on the corneal endothelium. Cornea. 2000;19(4):546–50.CrossRef Alp BN, Elibol O, Sargon MF, Aslan OS, Yanyali A, Karabas L, Talu H, Caglar Y. The effect of povidone iodine on the corneal endothelium. Cornea. 2000;19(4):546–50.CrossRef
20.
go back to reference Saedon H, Nosek J, Phillips J, Narendran N, Yang YC. Ocular surface effects of repeated application of povidone iodine in patients receiving frequent intravitreal injections. Cutan Ocul Toxicol. 2017;36(4):343–6.CrossRef Saedon H, Nosek J, Phillips J, Narendran N, Yang YC. Ocular surface effects of repeated application of povidone iodine in patients receiving frequent intravitreal injections. Cutan Ocul Toxicol. 2017;36(4):343–6.CrossRef
21.
go back to reference Bhavsar AR, Glassman AR, Stockdale CR, Jampol LM, For the diabetic retinopathy clinical research N. Elimination of topical antibiotics for intravitreous injections and the importance of using povidone-iodine: update from the diabetic retinopathy clinical research network. JAMA Ophthalmology. 2016;134(10):1181–3.CrossRef Bhavsar AR, Glassman AR, Stockdale CR, Jampol LM, For the diabetic retinopathy clinical research N. Elimination of topical antibiotics for intravitreous injections and the importance of using povidone-iodine: update from the diabetic retinopathy clinical research network. JAMA Ophthalmology. 2016;134(10):1181–3.CrossRef
22.
go back to reference Modjtahedi BS, van Zyl T, Pandya HK, Leonard RE, Eliott D. Endophthalmitis after intravitreal injections in patients with self-reported iodine allergy. Am J Ophthalmol. 2016;170:68–74.CrossRef Modjtahedi BS, van Zyl T, Pandya HK, Leonard RE, Eliott D. Endophthalmitis after intravitreal injections in patients with self-reported iodine allergy. Am J Ophthalmol. 2016;170:68–74.CrossRef
23.
go back to reference Friedman DA, Mason JO III, Emond T, Mcgwin G Jr. Povidone-iodine contact time and lid speculum use during intravitreal injection. Retina. 2013;33(5):975–81.CrossRef Friedman DA, Mason JO III, Emond T, Mcgwin G Jr. Povidone-iodine contact time and lid speculum use during intravitreal injection. Retina. 2013;33(5):975–81.CrossRef
24.
go back to reference Mathers WD, Lane JA, Zimmerman MB. Tear film changes associated with normal aging. Cornea. 1996;15(3):229–34.CrossRef Mathers WD, Lane JA, Zimmerman MB. Tear film changes associated with normal aging. Cornea. 1996;15(3):229–34.CrossRef
25.
go back to reference Oakley C, Allen P, Hooshmand J, Vote BJ. Pain and antisepsis after ocular administration of povidone-iodine versus chlorhexidine. Retina. 2018;38(10):2064-6.CrossRef Oakley C, Allen P, Hooshmand J, Vote BJ. Pain and antisepsis after ocular administration of povidone-iodine versus chlorhexidine. Retina. 2018;38(10):2064-6.CrossRef
26.
go back to reference Buck DA, Dawkins R, Kawasaki R, Sandhu SS, Allen PJ. Survey of Victorian ophthalmologists who use ranibizumab to treat age-related macular degeneration: to identify current practice and modifiable risk factors relevant to post-injection endophthalmitis. Clin Exp Ophthalmol. 2015;43(3):277–9.CrossRef Buck DA, Dawkins R, Kawasaki R, Sandhu SS, Allen PJ. Survey of Victorian ophthalmologists who use ranibizumab to treat age-related macular degeneration: to identify current practice and modifiable risk factors relevant to post-injection endophthalmitis. Clin Exp Ophthalmol. 2015;43(3):277–9.CrossRef
27.
go back to reference Green-Simms AE, Ekdawi NS, Bakri SJ. Survey of intravitreal injection techniques among retinal specialists in the United States. Am J Ophthalmol. 2011;151(2):329–32.CrossRef Green-Simms AE, Ekdawi NS, Bakri SJ. Survey of intravitreal injection techniques among retinal specialists in the United States. Am J Ophthalmol. 2011;151(2):329–32.CrossRef
28.
go back to reference Shiroma HF, Farah ME, Takahashi WY, Gomes AMV, Goldbaum M, Rodrigues EB. Survey: technique of performing intravitreal injection among members of the Brazilian retina and vitreous society (SBRV). Arq Bras Oftalmol. 2015;78(1):32–5.CrossRef Shiroma HF, Farah ME, Takahashi WY, Gomes AMV, Goldbaum M, Rodrigues EB. Survey: technique of performing intravitreal injection among members of the Brazilian retina and vitreous society (SBRV). Arq Bras Oftalmol. 2015;78(1):32–5.CrossRef
29.
go back to reference Li AL, Wykoff CC, Wang R, Chen E, Benz MS, Fish RH, Wong TP, Major JC Jr, Brown DM, Schefler AC, et al. Endophthalmitis after intravitreal injection: role of prophylactic topical ophthalmic antibiotics. Retina. 2016;36(7):1349–56.CrossRef Li AL, Wykoff CC, Wang R, Chen E, Benz MS, Fish RH, Wong TP, Major JC Jr, Brown DM, Schefler AC, et al. Endophthalmitis after intravitreal injection: role of prophylactic topical ophthalmic antibiotics. Retina. 2016;36(7):1349–56.CrossRef
30.
go back to reference Berkelman RL, Holland B, Anderson R. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol. 1982;15(4):635–9.CrossRef Berkelman RL, Holland B, Anderson R. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol. 1982;15(4):635–9.CrossRef
31.
go back to reference Zamora JL. Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg. 1986;151(3):400–6.CrossRef Zamora JL. Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg. 1986;151(3):400–6.CrossRef
32.
go back to reference Lacey R, Catto A. Action of povidone-iodine against methicillin-sensitive and-resistant cultures of Staphylococcus aureus. Postgrad Med J. 1993;69:S78.CrossRef Lacey R, Catto A. Action of povidone-iodine against methicillin-sensitive and-resistant cultures of Staphylococcus aureus. Postgrad Med J. 1993;69:S78.CrossRef
33.
go back to reference Roberts S, Severin G, Lavach J. Antibacterial activity of dilute povidone-iodine solutions used for ocular surface disinfection in dogs. Am J Vet Res. 1986;47(6):1207–10.PubMed Roberts S, Severin G, Lavach J. Antibacterial activity of dilute povidone-iodine solutions used for ocular surface disinfection in dogs. Am J Vet Res. 1986;47(6):1207–10.PubMed
34.
go back to reference Grimes S, Mein C, Trevino S. Preoperative antibiotic and povidone-iodine preparation of the eye. Ann Ophthalmol. 1991;23(7):263–6.PubMed Grimes S, Mein C, Trevino S. Preoperative antibiotic and povidone-iodine preparation of the eye. Ann Ophthalmol. 1991;23(7):263–6.PubMed
36.
go back to reference Ferguson A, Scott J, McGavigan J, Elton R, McLean J, Schmidt U, Kelkar R, Dhillon B. Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study. Br J Ophthalmol. 2003;87(2):163–7.CrossRef Ferguson A, Scott J, McGavigan J, Elton R, McLean J, Schmidt U, Kelkar R, Dhillon B. Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study. Br J Ophthalmol. 2003;87(2):163–7.CrossRef
37.
go back to reference Philips B, Fergusson S, Armstrong P, Anderson F, Wildsmith J. Surgical face masks are effective in reducing bacterial contamination caused by dispersal from the upper airway. Br J Anaesth. 1992;69(4):407–8.CrossRef Philips B, Fergusson S, Armstrong P, Anderson F, Wildsmith J. Surgical face masks are effective in reducing bacterial contamination caused by dispersal from the upper airway. Br J Anaesth. 1992;69(4):407–8.CrossRef
38.
go back to reference Wen JC, McCannel CA, Mochon AB, Garner OB. Bacterial dispersal associated with speech in the setting of intravitreous injections. Archives of ophthalmology. 2011;129(12):1551-4.CrossRef Wen JC, McCannel CA, Mochon AB, Garner OB. Bacterial dispersal associated with speech in the setting of intravitreous injections. Archives of ophthalmology. 2011;129(12):1551-4.CrossRef
39.
go back to reference Buck G, Kelly M. Effect of moisture content of the medium on colony morphology of campylobacter fetus subsp jejuni. J Clin Microbiol. 1981;14(5):585–6.CrossRef Buck G, Kelly M. Effect of moisture content of the medium on colony morphology of campylobacter fetus subsp jejuni. J Clin Microbiol. 1981;14(5):585–6.CrossRef
40.
go back to reference De Goffau MC, Yang X, van Dijl JM, Harmsen HJM. Bacterial pleomorphism and competition in a relative humidity gradient. Environ Microbiol. 2009;11(4):809–22. De Goffau MC, Yang X, van Dijl JM, Harmsen HJM. Bacterial pleomorphism and competition in a relative humidity gradient. Environ Microbiol. 2009;11(4):809–22.
41.
go back to reference Gnanasekaran S, Rogers S, Wickremasinghe S, Sandhu S. The effect of diluting povidone-iodine on bacteria growth associated with speech in the setting ofan outpatient intravitreal injection room. Clinical & Experimental Ophthalmology. 2015;43:63. Gnanasekaran S, Rogers S, Wickremasinghe S, Sandhu S. The effect of diluting povidone-iodine on bacteria growth associated with speech in the setting ofan outpatient intravitreal injection room. Clinical & Experimental Ophthalmology. 2015;43:63.
Metadata
Title
The effect of diluting povidone-iodine on bacterial growth associated with speech
Authors
Sivashanth Gnanasekaran
Sophie Rogers
Sanj Wickremasinghe
Sukhpal S. Sandhu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2019
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-019-1066-5

Other articles of this Issue 1/2019

BMC Ophthalmology 1/2019 Go to the issue